Posted by Michael Wonder on 01 Jun 2018
Recommendations made by the PBAC - April 2018
1 June 2018 - The recommendations from the April 2018 PBAC meeting are now available.
The PBAC considered (and recommended) two medicines:
- Filgrastim (Nivestim)
- Ponatinib hydrochloride (Iclusig)
The Committee's outcomes for these two medicines ARE NOT CLEAR. MAESTrO Database has sought advice from the PBAC Chairman on this matter. This advice will be noted (if provided) in a future issue of MAESTrO Daily. These outcomes will be added to the MAESTrO Database once they become clear.
